The Journal of Investigative Dermatology – Boston Collaborative Drug Surveillance Program (BCDSP)

Survival after Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis: a UK-based cohort study

By BCDSP November 19, 2020Uncategorized

Journal: The Journal of Investigative Dermatology Authors: Carole A Marxer, Noel Frey, Michael Bodmer, Andreas Bircher, Susan S Jick, Christoph R Meier, Julia Spoendlin NLM Citation: Marxer CA, Frey N, Bodmer M, Bircher A, Jick SS,…

Antibiotic Drug Use and the Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Population-Based Case-Control Study

By BCDSP December 19, 2017Uncategorized

Journal: The Journal of Investigative Dermatology Authors: Noel Frey 1, Andreas Bircher 2, Michael Bodmer 3, Susan S Jick 4, Christoph R Meier 5, Julia Spoendlin 1 NLM Citation: Frey N, Bircher A, Bodmer M, Jick SS, Meier CR, Spoendlin J.…

The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the UK

By BCDSP February 12, 2017Uncategorized

Journal: Journal of Investigative Dermatology Authors: Noel Frey 1, Janine Jossi 2, Michael Bodmer 3, Andreas Bircher 4, Susan S Jick 5, Christoph R Meier 6, Julia Spoendlin 1 NLM Citation: Frey N, Jossi J, Bodmer M, Bircher A, Jick SS, Meier CR,…

Risk of rosacea in patients with diabetes using insulin or oral antidiabetic drugs

By BCDSP May 8, 2013Uncategorized

Journal: The Journal of Investigative Dermatology Authors: Julia Spoendlin 1, Johannes J Voegel 2, Susan S Jick 3, Christoph R Meier 4 NLM Citation: Spoendlin J, Voegel JJ, Jick SS, Meier CR. Risk of rosacea in patients…

Spironolactone may reduce the risk of incident rosacea

By BCDSP April 17, 2013Uncategorized